INITS invests in a top-of-the-line machine for aseptic filling!

INITS is proud to announce its strengthened collaboration with @Cytiva, a global leader in biopharmaceutical innovation. This partnership is highlighted by the acquisition of the SA25 aseptic filling workcell, further enhancing our aseptic filling capabilities within our upcoming GMP facility.

This top-of-the-line machine offers exceptional flexibility and precision to support a wide range of clinical manufacturing needs:

✅ Class A isolator
✅ Batch sizes from 100 to 20,000 units
✅ Filling volumes ranging from 200 µL to 50 mL
✅ Compatible with vials (2R to 50R), syringes (1 to 10 mL), and cartridges (1 to 1.5 mL)

The SA25 aseptic filling workcell will be a central component of the Shared Manufacturing Organization (SMO), providing biotech companies with a fully integrated service – from tech transfer to IMP certification - within a secure and GMP-compliant environment.

Stay tuned for more updates as we prepare to open our new facility in 2026!

#INITS #Biomanufacturing #FillAndFinish #AsepticFilling #SA25 #GMP #Innovation #Biotech #SMO #GeneTherapy #CellTherapy #Biopharma #Cytiva #Partnership